Boston Scientific Cleared to Market Guidezilla Guide Extension Catheter

July 12, 2013—Boston Scientific Corporation (Natick, MA) announced that it has received US Food and Drug Administration 510(k) clearance and CE Mark approval for the Guidezilla guide extension catheter. The company has launched the device in the United States and Europe.

According to the company, the Guidezilla device is designed for efficient delivery of interventional devices, including balloons and stents, in situations where extra backup support is needed during complex percutaneous coronary intervention procedures. The Guidezilla's stainless steel hypotube shaft provides pushability and kink resistance. The hydrophilic coating on the outer diameter reduces friction, making it easier for interventional cardiologists to navigate difficult-to-reach areas, stated Boston Scientific.

“The Guidezilla device provides a new level of confidence and reassurance in treating complex lesions,” commented John Lasala, MD, in the company's press release. Dr. Lasala is Director, Cardiac Catheterization Lab at Barnes-Jewish Hospital, and Director of Interventional Cardiology at Washington University in St. Louis, Missouri. “I've found it can reduce the time and effort required in many complex procedures.”